newsfilter
← Latest News
GlobeNewswire·

Zealand Pharma to participate in the Jefferies Global Healthcare Conference

  • Zealand Pharma CEO Adam Steensberg will attend a fireside chat at the Jefferies Global Healthcare Conference in London on Monday, November 16, 2026, at 12:30pm CET.
  • A live audio webcast of the event will be available at https://event.summitcast.com/view/avibSrFufLKeoLRAEgMxy6/4z8azbzzY9moovdWsmARdB.
  • The webcast recording will be archived on Zealand Pharma's investor website at https://www.zealandpharma.com/investors/events-presentations/.
  • Zealand Pharma is a biotechnology firm headquartered in Copenhagen with a U.S. presence in Boston, focused on obesity & metabolic health.
  • The company has over 25 years of peptide R&D experience, utilizes AI/ML data platforms, & has more than 10 drug candidates in clinical development.
  • Two products from Zealand Pharma have reached the market, while three candidates are currently in late-stage development.
  • Investor contacts include Eric Rojas (VP, Head of Investor Relations) & Neshat Anis Ahmadi (Investor Relations Manager).
  • Media contacts include Rachel James-Owens (VP, Corporate Communications & Media Relations) & Andreas Hylleberg Mølleskov (Director, External Communications).